Noradrenergic Neural Substrates for Anxiety and Fear

Clinical Associations Based on Preclinical Research

D. S. Charney, J. D. Bremner, and D. E. Redmond, Jr.
Department of Psychiatry
Yale University School of Medicine
West Haven and Veterans Affairs Medical Center
West Haven, Connecticut 06516.


1. Anokhin KV, Mileusnic R, Shamakina IY, Rose SPR. Effects of early experience on c-fos gene expression in the chick forebrain. Brain Res 1991;544:101–107.

2. Aston-Jones G, Akaoka H, Charlety P, Chouvet G. Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 1991;11:760–769.

3. Aston-Jones G, Chiang C, Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. In: Barnes CD, Pomeiano O, eds. Progress in brain research. Amsterdam: Elsevier, 1991;501–519.

4. Aston-Jones G, Ennis M, Pieribone J, Nickel WT, Shipley MT. The brain nucleus locus coeruleus: restricted afferent control over a broad efferent network. Science 1986;234:734–737.

5. Aston-Jones G, Valentino RJ, Van Bockstaele EJ, Meyerson AT. Locus coeruleus, stress and post traumatic stress disorder: neurobiological and clinical parallels. In: Murburg M, ed. Catecholamine function in post traumatic stress disorder: emerging concepts. Washington, DC: American Psychiatric Press, 1994; in press.

6. Butler PD, Weiss JM, Stout JC, Nemeroff CB. Corticotropin releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 1990;10:(1):176–183.

7. Cameron OG, Lee MA, Curtis GC, McCann DS. Endocrine and physiological changes during spontaneous panic attacks. Psychoneuroendocrinology 1987;12:321–331.

8. Campean S, Hayward MD, Hope BT, Rosen JB, Nestler EJ, Davis M. Induction of the c-FOS proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res 1991;565:349–352.

9. Ceccatelli S, Villar MJ, Goldstein M, Hokfelt T. Expression of c-fos immunoreactivity in transmitter-characterized neurons after stress. Proc Natl Acad Sci USA 1989;86:9569–9573.

10. Cedarbaum JM, Aghajanian GK. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 1978;178:1–16.

11. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 1990;6:2908–2914.

12. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:294–305.

13. Charney DS, Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment. Arch Gen Psychiatry, 1985;42:458–467.

14. Charney DS, Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Arch Gen Psychiatry 1985;41:473–481.

15. Charney DS, Heninger GR, Breier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1984;41:751–763.

16. Charney DS, Woods SW, Goodman WK, Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 1987;144:1030–1036.

17. Charney DS, Woods SW, Heninger GR. Noradrenergic function in generalized anxiety disorder. Effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatry Res 1987;27:173–182.

18. Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 1992;86:273–282.

19. Charney DS, Woods SW, Price LH, Goodman WK, Glazer WM, Heninger, GR. Noradrenergic dysregulation in panic disorder. In: Ballenger JC, ed. Neurobiology of panic disorders. New York: Alan R Liss, 1990;91–105.

20. Craig AD. Spinal and trigeninal lamina 1 input to the locus coeruleus anterogradely labeled with Phaseolus vulgaris leucoagglutinin (PHA-L) in the cat and monkey. Brain Res 1992;584:325–328.

21. Craig AD, Linington AJ, Kniftki K-D. Significant differences in retrograde labeling of spinothalamic tract cells by horseradish peroxidase and fluorescent tracers fast blue and diamidino yellow. Exp Brain Res 1989;74:431–436.

22. Curtis G, Lee MA, Glitz DA, Cameron OG, Abelson J, Bronzo M. Growth hormone response to clonidine in anxiety disorders. Biol Psychiatry 1989;25:6A.

23. denBoer JA, Westenberg HGM. Serotonin function in panic disorder. A double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 1990;102:85–94.

24. Dunn AJ, Berridge CW. Corticotropin-releasing factor administration elicits a stress like activation of cerebral catecholaminergic systems. Pharmacol Biochem Behav 1987;27:27(4):685–691.

25. Edlund MJ, Swann AC, Davis CM. Plasma MHPG in untreated panic disorder. Biol Psychiatry 1987;22:1491–1495.

26. Finaly JM, Abercrombie ED. Stress induced sensitization of norepinephrine release in the medial prefrontal cortex. Soc Neurosci Abstr 1991;17:151.

27. Goddard AW, Woods SW, Sholomskas DE, Goodman WK, Charney DS, Heninger GR. Effects of the serotonin reuptake inhibitor fluvoxamine on noradrenergic function in panic disorder. Psychiatry Res 1993;48:119–133.

28. Havard HL, Buckland PR, O'Donovan MC, McGuffin P. The effect of antidepressant drugs on kainate receptor mRNA levels. Neuropharmacology 1991;30(6):675–677.

29. Ida Y, Tanaka M, Tsuda A, Tsujimaru S, Nagasaki N. Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: antagonism by Ro 15-1788. Life Sci 1985;37:2491–2498.

30. Irwin J, Ahluwalia P, Anisman H. Sensitization of norepinephrine activity following acute and chronic footshock. Brain Res 1986;379:98–103.

31. Justice A, Feldman SM, Brown LL. The nucleus locus coeruleus modulates local cerebral glucose utilization during noise stress in rats. Brain Res 1989;490:73–84.

32. Kaitin KI, Bliwise DL, Gleason C, Nino-Murcia G, Dement WC, Libet B. Sleep disturbance produced by electrical stimulation of the locus coeruleus in a human subject. Biol Psychiatry 1986;21:710–716.

33. Kinzie JD, Leung P. Clonidine in Cambodian patients with post traumatic stress disorder. J Nerv Ment Dis 1989;177:546–550.

34. Koob GF, Thatcher-Britton K, Britton Dr, Roberts DCS, Bloom FE. Destruction of the locus coeruleus or the dorsal NE bundle does not alter the release of punished responding by ethanol or chlordiazepoxide. Physiol Behav 1984;33:479–485.

35. Kosten TR, Mason JW, Giller EL, Ostroff RB, Harkness L. Sustained urinary norepinephrine and epinephrine elevation in posttraumatic stress disorder. Psychoneuroendocrinology 1987;12:13–20.

36. Lader M. The peripheral and central role of the catecholamines in the mechanisms of anxiety. Int Pharmacopsychiatry 1974;9:125–137.

37. Levine ES, Litto WJ, Jacobs BL. Activity of cat locus coeruleus noradrenergic neurons during the defense reaction. Brain Res 1990;531:189–195.

38. Luppi PH, Aston-Jones G, Akaoka H, Charlety P, Kovelowski C, Shipley MT, Zhu Y, Ennis M, Fort P, Chouvet G, Touvet M. Afferents to the rat locus coeruleus using choleteratoxin B subunit as a retrograde tracer. Neurosci Abstr 17:1991;1540.

39. Mathew RJ, Ho BT, Francis DJ, Taylor DL, Weinman ML. Catecholamines and anxiety. Acta Psychiatr Scand 1982;65(2):142–147.

40. McMahon SB, Wall PD. Electrophysiological mapping of brain stem projections of spinal cord lamina 1 cells in the rat. Brain Res 1985;333:19–26.

41. McNaughton N, Mason ST. The neuropsychology and neuropharmacology of the dorsal ascending noradrenergic bundle—a review. Prog Neurobiol 1980;14:157–219.

42. Melia KR, Nestler EJ, Duman RS. Chronic imipramine treatment normalized levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats. Psychopharmacology 1992;108:23–26.

43. Nesse RM, Cameron OG, Buda AJ, McCann DS, Curtis CG, Huber-Smith MJ. Urinary catecholamines and mitral valve prolapse in panic anxiety patients. Psychiatry Res 1985;14:67–75.

44. Nesse RM, Cameron OG, Curtis GC, McCann DS, Huber-Smith MJ. Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry 1984;41:771.

45. Nisenbaum LK, Zigmund MJ, Sved AF, Abercrombie ED. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. J Neurosci 1991;11:1478–1484.

46. Nutt DJ. Altered alpha2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989;46:165–169.

47. Pavcovich LA, Cancela LM, Volosin M, Molina VA, Ramirez OA. Chronic stress-induced changes in locus coeruleus neuronal activity. Brain Res Bull 1990;24:293–296.

48. Pohl R, Yeragani VK, Balon R. Effects of isoproterenol in panic disorder patients after antidepressant treatment. Biol Psychiatry 1990;28:203–214.

49. Pohl R, Yeragani VK, Balon R, Rainey JM, Lycaki H, Ortiz R, Berchou R, Weinberg P. Isoproterenol induced panic attacks. Biol Psychiatry 1988;24:891–902.

50. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorders. Am J Psychiatry 1992;149:999–1010.

51. Rasmussen K, Aghajanian GK. Failure to block responses to locus coeruleus neurons to somatosensory stimuli by destruction of two major afferent nucli. Synapse 1989;4:162–164.

52. Rasmussen K, Morilak DA, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res 1986;371(2):324–334.

53. Redmond DE Jr. Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987;467–974.

54. Redmond DE, Huang YH. New evidence for a locus coeruleus norepinephrine connection with anxiety. Life Sci 1979;25:2149–2162.

55. Redmond DE Jr, Huang YH, Snyder DR, Maas JW. Behavioral effects of stimulation of the locus coeruleus in the stumptail monkey (Macaca arctoides). Brain Res 1976;116:502–507.

56. Redmond DE Jr, Katz MM, Maas JW, Swann A, Casper R. Cerebrospinal fluid biogenic amine metabolite relationships with behavioral measurements in unipolar and bipolar depressed manic and healthy control subjects. Arch Gen Psychiatry 1986;43:938–947.

57. Roth WT, Margraf J, Ehlers A, Taylor CB, Maddock RJ, Davies S, Agras WS. Stress reactivity in panic disorder. Arch Gen Psychiatry 1992;49:301–310.

58. Savaki HE, Kadekaro M, McCulloch J, Sokoloff L. The central noradrenergic system in the rat: metabolic mapping with alpha adrenergic blocking agents. Brain Res 1982;234:65–79.

59. Sevy S, Papadimitriou GN, Surmont DW, Goldman S, Mendlewicz J. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects. Biol Psychiatry 1989;25:141–152.

60. Sheehan DV, Davidson J, Manschrek T. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 1983;3:28–31.

61. Sheehan DV, Raj AB, Sheehan KH, Soto S. The relative efficacy of buspirone, imipramine, and placebo in panic disorder. A preliminary report. Pharmacol Biochem Behav 1988;29:815–817.

62. Shirao I, Tsuda A, Yoshisshige I, Tsujimaru S, Satoh H, Oguchi M, Tanaka M, Inanaga K. Effect of acute ethanol administration on noradrenaline metabolism in brain regions of stressed and nonstressed rats. Pharmacol Biochem Behav 1988;30:769–773.

63. Siever LJ, Insel TR, Jimerson DC, Lake CR, Uhde TW, Aloi J, Murphy DL. Growth hormone response to clonidine in obsessive–compulsive patients. Br J Psychiatry 1983;142:184–187.

64. Simson PE, Weiss JM. Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology 1988;1:287–295.

65. Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolau A, Heninger GR, Charney DS. Abnormal noradrenergic function in post-traumatic stress disorder. Arch Gen Psychiatry 1993;181:31–37.

66. Stone EA, Zhang Y, John S, Filer D, Bing G. Effect of locus coeruleus lesion on c-fos expression in the cerebral cortex caused by yohimbine injection or stress. Brain Res 1993;603:181–185.

67. Svensson TH. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain. Putative implications for psychiatry and psychopharmacology. Psychopharmacology 1987;92:1–10.

68. Sweeney DR, Maas JW, Heninger GR. State anxiety, physical activity, and urinary 3-methoxy-4-hydroxyphenethylene glycol excretion. Arch Gen Psychiatry 1978;35:1418–1423.

69. Tanaka M, Kohno V, Tsuda A, Nakagawa R, Ida Y, Limori K, Nagasaki N. Differential effects of morphine on noradrenaline release in brain regions of stressed and nonstressed rats. Brain Res 1983;275:105–115.

70. Tanaka T, Yokoo H, Mizoguchi K, Yoshida M, Tsuda A, Tanaka M. Noradrenaline release in rat amygdala is increased by stress: studies with intracerebral microdialysis. Brain Res 1991;544:174–181.

71. Tanaka T, Yokoo H, Tsuda A, Tanaka M. Stress increased hypothalamic noradrenaline release studied by intracerebral dialysis method. Neuroscience 1990;16:293–300.

72. Tancer ME, Uhde TW. Neuroendocrine, physiologic, and behavioral responses to clonidine in patients with social phobia. Biol Psychiatry 1989;25:189–190.

73. Torda T, Kvetnansky R, Petrikova M. Effect of repeated immobilization stress on rat central and peripheral adrenoceptors. In: Usdin E, Kvetnansky R, Axelrod J, eds. Stress: the role of catecholamines and other neurotransmitters. New York: Gordon & Breach, 1984;691–701.

74. Tsaltas E, Gray JA, Fillenz M. Alleviation of response suppression to conditioned aversive stimuli by lesions of the dorsal noradrenergic bundle. Behav Brain Res 1987;13:115–127.

75. Uhde TW, Boulenger J-P, Post RM, Siever LJ, Vittone BJ, Jimerson DC, Roy-Byrne PP. Fear and anxiety: relationship to noradrenergic function. Psychopathology 1984;17(suppl 3):8–23.

76. Uhde TW, Joffe RT, Jimerson DC, Post RM. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry 1988;23:575–585.

77. Uhde TW, Murray MB, Vittone BJ, Siever LJ, Bouelenger JP, Klein E, Mellman TA. Behavioral and physiological effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry 1989;46:170–177.

78. Uhde TW, Siever IJ, Post RM, Jimerson DC, Boulenger J-P, Buchsbaum MS. The relationship of plasma-free MHPG to anxiety and psychophysical pain in normal volunteers. Psychopharmacol Bull 1982;18:129–132.

79. U'Prichard DC, Kvethansky R. Central and peripheral adrenergic receptors in acute and repeated immobilization stress. In: Usdin E, Kvetnansky R, Kopin IJ, eds. Catecholamines and stress: recent advances. Amsterdam: Elsevier, 1980;299–308.

80. Valentino RJ, Foote SL. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci 1988;8:1016–1025.

81. Van Bockstaele EJ, Pieribone VA, Aston-Jones G. Diverse afferents converge on the nucleus paragigantocellularis in the rat ventrolateral medulla: retrograde and anterograde tracing studies. J Comp Neurol 1989;290:561–584.

82. Verleye M, Bernet F. Behavioral effects of lesions of the central noradrenergic bundles in the rat. Pharmacol Biochem Behav 1983;19:407–414.

83. Weiner H. The psychobiology of anxiety and fear. In: Diagnosis and treatment of anxiety disorders. Washington, DC: American Psychiatric Press, 1984;33–62.

84. Weiss SRB, Post RM, Pert A, Woodward R, Murman D. Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol Biochem Behav 1989;34:655–661.

85. Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR. Situational panic attacks: behavioral, physiological, and biochemical characterization. Arch Gen Psychiatry 1987;44:365–375.

86. Woods SW, Hoffer PB, McDougle CJ, Seibyl JP, Krystal JH, Heninger GR, Charney DS. Cerebral noradrenergic function in panic disorder. Submitted for publication.

87. Yehuda R, Southwick SM, Giller EL. Urinary catecholamine excretion and severity of post-traumatic stress disorder in Vietnam combat veterans. J Nerv Ment Dis 1992;180:321–325.

88. Yokoo H, Tanaka M, Yoshida M, Tsuda A, Tanaka T, Mizoguchi K. Direct evidence of conditioned fear-elicited enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis. Brain Res 1990;536:305–308.

Back To Chapter

published 2000